Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

4.0%

2 terminated/withdrawn out of 50 trials

Success Rate

90.0%

+3.5% vs industry average

Late-Stage Pipeline

20%

10 trials in Phase 3/4

Results Transparency

33%

6 of 18 completed trials have results

Key Signals

14 recruiting6 with results

Enrollment Performance

Analytics

N/A

16(55.2%)

Phase 4

5(17.2%)

Phase 3

5(17.2%)

Phase 2

2(6.9%)

Phase 1

1(3.4%)

29Total

N/A(16)

Phase 4(5)

Phase 3(5)

Phase 2(2)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (50)

Showing 20 of 50 trials

NCT04929418Not ApplicableCompleted

Differential Adaptation of Renal Function in Intense Physical Exercise

Role: collaborator

NCT07394790Not ApplicableRecruiting

Effectiveness of a Physical Exercise Prescription Program in Primary Care for Adults Aged 65 and Older: PREFIS-AP

Role: lead

NCT07277387Not Yet Recruiting

Plasma Host-Microbe Proteomics to Predict Complications in High-risk Febrile Neutropenia

Role: lead

NCT06977295Recruiting

Evaluation of a Diagnostic Software for Coronary Artery Disease Using Retrospective CCTA Data (CODEX-1 Study)

Role: lead

NCT06378190Phase 1Recruiting

Treatment of Relapsed or Refractory B-cell Lymphoma With Chimeric Antigen Receptor (CAR) T-cell Therapy Produced by a New Technology

Role: lead

NCT07015892Phase 3Recruiting

Dose-Escalation Radiotherapy in Limited-Stage Small Cell Lung Cancer: A Phase III Randomized Trial

Role: lead

NCT06905834Phase 2Not Yet Recruiting

Evaluation of Allogenic Mesenchymal Stem Cell (MSC) Injection Therapy for Refractory Graft-versus-Host Disease (GVHD) Unresponsive to Conventional Treatments

Role: lead

NCT07295483Recruiting

Predictors of Long-Term Evolution in Long COVID; 4-Year Follow-Up. (BioICOPER Follow-up Study)

Role: lead

NCT07195331Phase 4Recruiting

Comparison Between Standard and Reduced Doses of Indocyanine Green in Fluorescence Cholangiography During Laparoscopic Cholecystectomy.

Role: lead

NCT07447375Not ApplicableRecruiting

Exercise During Hemodialysis: Impact on Sarcopenia and Sleep Quality

Role: collaborator

NCT07348484Not Yet Recruiting

Urinary Biomarker-Based Diagnostic and Monitoring System for Chronic Kidney Disease and Real-World Effectiveness of SGLT2 Inhibitors

Role: lead

NCT07303361Not ApplicableCompleted

Effect of Active Mandibular Techniques and Specific Cranio-cervical Therapeutic Exercise in Patients With Temporomandibular Disorders and Bruxism (AMaCe-TB)

Role: lead

NCT07268391Not ApplicableNot Yet Recruiting

Using Advanced CT Scans and Blood Markers to Better Understand Heart Damage and Recovery After a Heart Attack

Role: lead

NCT06188910Not ApplicableCompleted

Neurofeedback and Nomophobia in Young Adults

Role: collaborator

NCT07064330Recruiting

Next-gen Flow Cytometry to Find Immune Profiles, Treatment Response, and Toxicity Markers in Skin Cancer Patients Treated With Cemiplimab.

Role: lead

NCT05419947Phase 4Completed

Clinical Trial for the Optimization of Indocyanine Green Administration in NIRF-C During L.Cholecystectomy.

Role: collaborator

NCT03739476Phase 3Terminated

Clinical Trial With Quetiapine Prophylaxis Postoperative Delirium in High Risk Surgical Patients

Role: collaborator

NCT06379945Recruiting

Unified platforM for a Better integRal Evaluation of MyeLodyspLastic Syndromes in SpAin-Strategy for Unraveling Personalized genoMic Medicine in Public heAlth System (UMBRELLA-SUMMA)

Role: lead

NCT06382844Recruiting

Novel Flow-cytometry Approaches to Improve the Detection of Tumor Cells in CTCL

Role: lead

NCT06453174Active Not Recruiting

CLinical Utility of Early Intervention Including the 5-Step Precision Medicine (5SPM) Method in First-episode Psychosis: The CLUMP Project

Role: lead